Intensive chemotherapy with or without gemtuzumab ozogamicin in patients with NPM1-mutated acute myeloid leukaemia (AMLSG 09–09): a randomised, open-label, multicentre, phase 3 trialHartmut Döhner,Daniela Weber,Julia Krzykalla,Walter Fiedler,Michael W M Kühn,Thomas Schroeder,Karin Mayer,Michael Lübbert,Mohammed Wattad,Katharina Götze,Lars Fransecky,Elisabeth Koller,Gerald Wulf,Jan Schleicher,Mark Ringhoffer,Richard Greil,Bernd Hertenstein,Jürgen Krauter,Uwe M Martens,David NachbaurThe Lancet Haematology（2023）引用 0|浏览5暂无评分AI 理解论文溯源树样例生成溯源树，研究论文发展脉络Chat Paper正在生成论文摘要
